SALT LAKE CITY, June 8 /PRNewswire-FirstCall/ -- BSD Medical Corp. (Amex: BSM - News) today highlighted key research reported at the European Society for Hyperthermic Oncology (ESHO) meetings recently concluded in Berlin, Germany. In addition to the presentations on cancer therapy advancement, it was also noted that the location of the conference in Berlin presented an excellent opportunity to expose leaders in new cancer therapy development to the BSD-2000/3D/MR system, by BSD Medical, at Charite Medical School of Humboldt University. The BSD-2000/3D/MR combines simultaneous three- dimensional steering of RF energy focused on tumors with magnetic resonance imaging of the treatment in progress, color-differentiated by temperature. Many key attendees at the conference, including several who are active prospects for the system, reviewed the BSD-2000/3D/MR.
